Cardiac arrest & resuscitation

Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets

ChestPublished Retrospective analysis of prospectively collected registry and trial data

Authors' conclusion

TTM32-36 was significantly associated with a better outcome in patients with low and high severity at ICU admission assessed according to the mCAHP score.

Study context

Population
Comatose patients after OHCA, Sudden Death Expertise Center (SDEC) registry (France, 2011–2017) and Resuscitation Outcomes Consortium Continuous Chest Compressions (ROC-CCC) trial (US and Canada, 2011–2015)2,723 SDEC
Exposure
TTM32-36 vs no TTM32-36, by mCAHP severity tertile at ICU admission
Outcome
Favorable neurologic status at hospital discharge
Follow-up
Hospital discharge
Methodological detailssubgroup analysis by severity tertiles, multiple logistic regression, two data sets (SDEC registry, ROC-CCC trial)
  • Subgroup analysis by severity tertiles
  • Multiple logistic regression
  • Two data sets (SDEC registry, ROC-CCC trial)

Main finding

As reported in the abstract

Favorable neurologic status by mCAHP severity tertile (subgroups)
TTM32-36Adjusted odds ratio (95% CI)P value
SDEC, low severity
1.63(1.15–2.30)
P = 0.006
SDEC, high severity
1.94(1.06–3.54)
P = 0.030
ROC-CCC, low severity
1.36(1.05–1.75)
P = 0.020
ROC-CCC, high severity
2.42(1.38–4.24)
P = 0.002

Observational data: associations, not effects.

Further findings

Favorable neurologic status at hospital discharge, overall

SDEC data set
728 (27%)
ROC-CCC data set
1,239 (29%)

Original publication

Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets. Chest. Published 30 October 2022. doi:10.1016/j.chest.2022.10.023

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.